EUVIMEDEUVIMED entdecken
Leserbrief

Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy

Saarang R Deshpande iD, Debbie Jiang iD, Rebecca K Leaf iD, Andrew Song iD, P Connor Johnson iD, Caron Jacobson iD, Jeremy Abramson iD, Hanny Al-Samkari iD

American Journal of Hematology · 2026-12 · 101 (12) · 3067-3071

DOI: 10.1002/ajh.70505 ↗

Kurz gefasst

Leserbrief in der Zeitschrift American Journal of Hematology, online erschienen am 23.09.2026. Verfasst von Saarang R Deshpande und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Classical Hematology, Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, Massachusetts, USA. Die Arbeit nennt 19 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

Stichwörter der Autor:innen

bispecific T‐cell engagerschimeric antigen receptor T‐cell therapyhematologic neoplasmsimmune effector cell therapyimmune thrombocytopenia

Autor:innen und Institutionen

  • Division of Classical Hematology, Mass General Brigham Cancer Institute, Massachusetts General Hospital, Boston, Massachusetts, USA.
  • Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.
  • Division of Hematologic Malignancy, Mass General Brigham Cancer Institute, Boston, Massachusetts, USA.

ORCID-Profile: Saarang R Deshpande, Debbie Jiang, Rebecca K Leaf, Andrew Song, P Connor Johnson, Caron Jacobson, Jeremy Abramson, Hanny Al-Samkari

Zitieren

APA

Deshpande, S. R., Jiang, D., Leaf, R. K., Song, A., Johnson, P. C., Jacobson, C., Abramson, J., & Al-Samkari, H. (2026). Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy. American Journal of Hematology, 101(12), 3067-3071. https://doi.org/10.1002/ajh.70505

Vancouver

Deshpande SR, Jiang D, Leaf RK, Song A, Johnson PC, Jacobson C, et al. Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy. American Journal of Hematology. 2026;101(12):3067-3071. doi:10.1002/ajh.70505

BibTeX
@article{Deshpande2026,
  author = {Deshpande, Saarang R and Jiang, Debbie and Leaf, Rebecca K and Song, Andrew and Johnson, P Connor and Jacobson, Caron and Abramson, Jeremy and Al-Samkari, Hanny},
  title = {Immune Effector Cell Therapies for Immune Thrombocytopenia Concurrent With Hematologic Malignancy},
  journal = {American Journal of Hematology},
  year = {2026},
  volume = {101},
  number = {12},
  pages = {3067--3071},
  doi = {10.1002/ajh.70505}
}
Kostenlos starten →